R&D How AI is propelling pharma into the modern age Artificial intelligence’s role in drug discovery is apparent and well-known, with start-ups like
Views & Analysis How AI-powered adaptive design helped Eisai launch Leqembi At DPHARM 2023 in Boston, Eisai insiders described the Bayesian design of Leqembi's phase 2 trial.
R&D Turning drug development on its head In episode 98 of the pharmaphorum podcast , host Jonah Comstock and Alchemab CEO Young Kwon discuss innovative new routes to drug discovery
R&D The SPC waiver: How do we restore the intended balance betwe... Biosimilars promote cost-effective solutions to critical healthcare challenges.
R&D Driving data & analytics transformation in life sciences The field of life sciences is witnessing a remarkable era of innovation, characterised by breakthroughs across scientific domains that are revolutionising drug discovery and development.
R&D GLP-1 weight loss drugs: An overview and update GLP-1 agonists like Ozempic, Wegovy, and Mounjaro are dramatically changing the field of medically-assisted weight loss.
News UK budget includes £1bn biopharma investment package UK Chancellor John Healey's first Budget speech included a £1bn-plus industry investment package at sites in Manchester, Oxford, and Loughborough.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
